We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Solving POC Test Communication Challenges to EMRs

By LabMedica International staff writers
Posted on 02 Dec 2009
According to a leading healthcare market research publisher, a key question users of glucose monitors and other point-of-care (POC) tests may ask is "does the POC test talk to the user's electronic medical record (EMR).” As wireless communication becomes standard in hospitals, it is incumbent on the US$13 billion worldwide market for POC test systems to participate fully in this phenomenon. More...


Connectivity is a high priority issue in order for hospital POC testing and critical care device markets to expand, according to the findings of a recent market report from healthcare market research publisher Kalorama Information (New York, NY, USA). "On-the-spot access to patient information and care guidelines is part of the healthcare quality imperative of the 21st century,” noted Shara Rosen, Kalorama Information's diagnostics analyst. "Cost reduction pressures and the need for shortened in-patient stays are promoting the use of wireless communication in and out of hospitals.”

While the worldwide medical community is racing to embrace EMR and telemedicine, most POC test devices currently have limited connectivity capabilities and cannot participate. At this time, all major lab-based instruments interface automatically to a laboratory information system (LIS) or hospital information system (HIS) system. However, many glucose monitors in hospital wards do not have this connectivity capability and so they do not become part of a patient's EMR. The same applies to almost all pregnancy and urinalysis tests performed in the hospital but outside the laboratory.

Within today's hospital environment of limited resources, cost pressures, decentralized patient information, large investment in new technologies and increased regulatory scrutiny, healthcare is more challenging than ever before. POC testing is poised to provide a solution to some of these economic pressures. However, without first-class connectivity solutions, POC testing cannot provide the expected benefits in improved patient care that will lead to cost reductions. "Any manufacturers who want to make their POC products incredibly valuable should make sure they can link up with major EMR systems,” said Ms. Rosen.

Beyond the connectivity issue, the next frontier is continuous monitoring of patients in acute care and in selected treatment areas such as dialysis, intensive care, and the operating room (OR). Moreover, as the number of POC tests continues to grow, potential users will not want to learn to use a large number of devices. Therefore, considerable research has been ongoing for about a decade on a multipurpose POC platform that can run chemistries and immunoassays.

Kalorama Information supplies independent market research in the life sciences, as well as a full range of custom research services.

Related Links:
Kalorama Information


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.